vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Bilibili Inc. (BILI). Click either name above to swap in a different company.
Bilibili Inc. is the larger business by last-quarter revenue ($1.3B vs $950.5M, roughly 1.3× Astrana Health, Inc.). Bilibili Inc. runs the higher net margin — 6.0% vs 0.7%, a 5.3% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 26.2%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 27.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Bilibili, nicknamed B Site, is a Chinese online video sharing website based in Shanghai where users can submit, view, and add overlaid commentary on videos.
ASTH vs BILI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.3B |
| Net Profit | $6.6M | $75.7M |
| Gross Margin | — | 37.0% |
| Operating Margin | 1.9% | 5.8% |
| Net Margin | 0.7% | 6.0% |
| Revenue YoY | 42.9% | 26.2% |
| Net Profit YoY | 184.4% | 143.0% |
| EPS (diluted) | $0.12 | $1.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.3B | ||
| Q3 25 | $956.0M | $1.1B | ||
| Q2 25 | $654.8M | $1.0B | ||
| Q1 25 | $620.4M | $965.1M | ||
| Q4 24 | $665.2M | $1.0B | ||
| Q3 24 | $478.7M | $1.0B | ||
| Q2 24 | $486.3M | $843.1M | ||
| Q1 24 | $404.4M | $784.5M |
| Q4 25 | $6.6M | $75.7M | ||
| Q3 25 | $373.0K | $65.9M | ||
| Q2 25 | $9.4M | $30.5M | ||
| Q1 25 | $6.7M | $-1.5M | ||
| Q4 24 | $-7.8M | $-176.0M | ||
| Q3 24 | $16.1M | $11.4M | ||
| Q2 24 | $19.2M | $83.7M | ||
| Q1 24 | $14.8M | $-105.9M |
| Q4 25 | — | 37.0% | ||
| Q3 25 | — | 36.7% | ||
| Q2 25 | — | 36.5% | ||
| Q1 25 | — | 36.3% | ||
| Q4 24 | — | 36.2% | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 28.3% |
| Q4 25 | 1.9% | 5.8% | ||
| Q3 25 | 2.0% | 4.6% | ||
| Q2 25 | 3.1% | 3.4% | ||
| Q1 25 | 3.3% | 0.2% | ||
| Q4 24 | 0.1% | -16.0% | ||
| Q3 24 | 5.9% | 0.9% | ||
| Q2 24 | 6.2% | 9.5% | ||
| Q1 24 | 7.5% | -14.5% |
| Q4 25 | 0.7% | 6.0% | ||
| Q3 25 | 0.0% | 6.1% | ||
| Q2 25 | 1.4% | 3.0% | ||
| Q1 25 | 1.1% | -0.2% | ||
| Q4 24 | -1.2% | -17.5% | ||
| Q3 24 | 3.4% | 1.1% | ||
| Q2 24 | 3.9% | 9.9% | ||
| Q1 24 | 3.7% | -13.5% |
| Q4 25 | $0.12 | $1.14 | ||
| Q3 25 | $0.01 | $1.05 | ||
| Q2 25 | $0.19 | $0.51 | ||
| Q1 25 | $0.14 | $0.00 | ||
| Q4 24 | $-0.14 | $0.21 | ||
| Q3 24 | $0.33 | $-0.03 | ||
| Q2 24 | $0.40 | $-0.20 | ||
| Q1 24 | $0.31 | $-1.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $2.7B |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $779.3M | $2.2B |
| Total Assets | $2.2B | $5.9B |
| Debt / EquityLower = less leverage | — | 0.62× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $2.7B | ||
| Q3 25 | $463.4M | $2.4B | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | $1.9B | ||
| Q4 24 | $290.8M | $1.8B | ||
| Q3 24 | $350.3M | $11.7B | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | $1.1B |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $700.3M | ||
| Q4 24 | — | $662.5M | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $684.5M |
| Q4 25 | $779.3M | $2.2B | ||
| Q3 25 | $775.5M | $2.1B | ||
| Q2 25 | $765.5M | — | ||
| Q1 25 | $745.4M | $2.0B | ||
| Q4 24 | $712.7M | $1.9B | ||
| Q3 24 | $704.6M | $13.7B | ||
| Q2 24 | $678.9M | — | ||
| Q1 24 | $653.5M | $1.9B |
| Q4 25 | $2.2B | $5.9B | ||
| Q3 25 | $2.2B | $5.6B | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | $4.6B | ||
| Q4 24 | $1.4B | $4.5B | ||
| Q3 24 | $1.3B | $32.0B | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | $4.2B |
| Q4 25 | — | 0.62× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $263.1M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | 3.47× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $263.1M | ||
| Q3 25 | $10.0M | $283.2M | ||
| Q2 25 | $90.9M | $277.7M | ||
| Q1 25 | $16.6M | $179.4M | ||
| Q4 24 | $-10.9M | $191.9M | ||
| Q3 24 | $34.0M | $2.2B | ||
| Q2 24 | $23.2M | — | ||
| Q1 24 | $6.0M | $88.3M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | $174.5M | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | 18.1% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | 0.5% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | -0.44× | 3.47× | ||
| Q3 25 | 26.69× | 4.30× | ||
| Q2 25 | 9.65× | 9.11× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 195.23× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BILI
| Value-added services (VAS) | $466.4M | 37% |
| Advertising | $435.0M | 34% |
| Mobile games | $220.3M | 17% |
| Other | $80.8M | 6% |
| IP derivatives and others | $68.2M | 5% |
